(Q33551996)

28 July 2017

title

Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine (English)

1 reference

https://api.crossref.org/works/10.1136/ARD.38.4.356

28 July 2017

0 references

placebo-controlled trial

1 reference

1 reference

1 reference

27 June 2022

1 reference

https://api.crossref.org/works/10.1136/ARD.38.4.356

27 June 2022

author name string

D. E. Furst

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

27 June 2022

P. J. Clements

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

27 June 2022

R. Harris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

27 June 2022

M. Ross

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

27 June 2022

J. Levy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

27 June 2022

H. E. Paulus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

27 June 2022

language of work or name

English

0 references

publication date

1 August 1979

1 reference

full work available at URL

28 July 2017

https://europepmc.org/articles/PMC1000371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

https://europepmc.org/articles/PMC1000371?pdf=render

27 June 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A386962

https://syndication.highwire.org/content/doi/10.1136/ard.38.4.356

27 June 2022

1 reference

https://api.crossref.org/works/10.1136/ARD.38.4.356

Annals of the Rheumatic Diseases

27 June 2022

published in

1 reference

28 July 2017

volume

38

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

356-361

1 reference

N-acetylcysteine inactivates migration inhibitory factor and delayed hypersensitivity reactions.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Lymphokine stimulation of collagen accumulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Failure of dimethyl sulfoxide in the treatment of scleroderma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Muscle disease in progressive systemic sclerosis. diagnostic and therapeutic considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

An Assessment of Grip Strength Measurement in Rheumatoid Arthritis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1000371

Effect of thiols in biological systems on protein sulfhydryl content

31 October 2018

1 reference

12 December 2020

Letter: Treatment of scleroderma

1 reference

12 December 2020

Cutaneous extensibility in health and disease

1 reference

12 December 2020

Progressive systemic sclerosis (diffuse scleroderma). A follow-up report of treatment with potaba

1 reference

12 December 2020

Lymphocyte response to mitogens in progressive systemic sclerosis

1 reference

12 December 2020

Generalized scleroderma. Treatment with an immunosuppressive agent

1 reference

12 December 2020

The reduction of experimentally induced inflammation by sulfhydryl compounds

1 reference

12 December 2020

AN EARLY PULMONARY PHYSIOLOGIC ABNORMALITY IN PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA)

1 reference

12 December 2020

Pulmonary function in scleroderma

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.38.4.356

1 reference

28 July 2017

1 reference

28 July 2017

1 reference